Patents by Inventor Jimmy Borloo

Jimmy Borloo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN CCR8 BINDERS
    Publication number: 20240076391
    Abstract: The present invention relates to human CCR8 (hCCR8) binders, wherein the hCCR8 binder is cross-reactive with a non-human primate CCR8. Such binders are particularly useful for the depletion of intra-tumoural regulatory T-cells and immunotherapy in general.
    Type: Application
    Filed: December 23, 2021
    Publication date: March 7, 2024
    Inventors: Hui Qi Lu, Catelijne Stortelers, Nadia Van Boxel, Shanna Van Zwam, Jimmy Borloo, Bruno Dombrecht, Jo Van Ginderachter, Pascal Merchiers, Rosa Martin
  • NON-BLOCKING HUMAN CCR8 BINDERS
    Publication number: 20240052044
    Abstract: The present invention relates to human CCR8 (hCCR8) binders, wherein the hCCR8 binder is a non-blocking binder of hCCR8.
    Type: Application
    Filed: December 23, 2021
    Publication date: February 15, 2024
    Inventors: Hui Qi Lu, Catelijne Stortelers, Nadia Van Boxel, Shanna Van Zwam, Jimmy Borloo, Bruno Dombrecht, Jo Van Ginderachter, Pascal Merchiers, Rosa Martin
  • MURINE CROSS-REACTIVE HUMAN CCR8 BINDERS
    Publication number: 20240052045
    Abstract: The present invention relates to human CCR8 (hCCR8) binders, wherein the hCCR8 binder is cross-reactive with murine CCR8. Such binders are particularly useful for the depletion of intra-tumoural regulatory T-cells and immunotherapy in general.
    Type: Application
    Filed: December 23, 2021
    Publication date: February 15, 2024
    Inventors: Hui Qi Lu, Catelijne Stortelers, Nadia Van Boxel, Shanna Van Zwam, Jimmy Borloo, Bruno Dombrecht, Jo Van Ginderachter, Pascal Merchiers, Rosa Martin
  • vaccine
    Patent number: 10946077
    Abstract: The present invention relates to nucleotide sequences encoding Cooperia antigens, as well as to recombinant DNA molecules containing such nucleotide sequences and host cells expressing these nucleotide sequences. The invention further relates to Cooperia proteins, to methods for the production of the proteins, nucleotide sequences, recombinant DNA molecules and hosts. Furthermore, the invention relates to vaccines which induce protective immunity against infection by parasitic nematodes such as species of the genus Cooperia and to methods for preparing such a vaccine.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: March 16, 2021
    Assignee: Universiteit Gent
    Inventors: Peter Geldhof, Jimmy Borloo, Edwin Claerebout, Jozef Vercruysse
  • COOPERIA VACCINE
    Publication number: 20180369349
    Abstract: The present invention relates to nucleotide sequences encoding Cooperia antigens, as well as to recombinant DNA molecules containing such nucleotide sequences and host cells expressing these nucleotide sequences. The invention further relates to Cooperia proteins, to methods for the production of the proteins, nucleotide sequences, recombinant DNA molecules and hosts. Furthermore, the invention relates to vaccines which induce protective immunity against infection by parasitic nematodes such as species of the genus Cooperia and to methods for preparing such a vaccine.
    Type: Application
    Filed: September 10, 2018
    Publication date: December 27, 2018
    Applicant: Universiteit Gent
    Inventors: Peter Geldhof, Jimmy Borloo, Edwin Claerebout, Jozef Vercruysse
  • Cooperia vaccine
    Patent number: 10105424
    Abstract: The present invention relates to nucleotide sequences encoding Cooperia antigens, as well as to recombinant DNA molecules containing such nucleotide sequences and host cells expressing these nucleotide sequences. The invention further relates to Cooperia proteins, to methods for the production of the proteins, nucleotide sequences, recombinant DNA molecules and hosts. Furthermore, the invention relates to vaccines which induce protective immunity against infection by parasitic nematodes such as species of the genus Cooperia and to methods for preparing such a vaccine.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: October 23, 2018
    Assignee: Universiteit Gent
    Inventors: Peter Geldhof, Jimmy Borloo, Edwin Claerebout, Jozef Vercruysse
  • COOPERIA VACCINE
    Publication number: 20150265687
    Abstract: The present invention relates to nucleotide sequences encoding Cooperia antigens, as well as to recombinant DNA molecules containing such nucleotide sequences and host cells expressing these nucleotide sequences. The invention further relates to Cooperia proteins, to methods for the production of the proteins, nucleotide sequences, recombinant DNA molecules and hosts. Furthermore, the invention relates to vaccines which induce protective immunity against infection by parasitic nematodes such as species of the genus Cooperia and to methods for preparing such a vaccine.
    Type: Application
    Filed: October 8, 2013
    Publication date: September 24, 2015
    Applicant: UNIVERSITEIT GENT
    Inventors: Peter Geldhof, Jimmy Borloo, Edwin Claerebout, Jozef Vercruysse